Nifty Pharma Today: Index Performance, Stocks & Analysis

Nifty Pharma today closed on a mildly negative note, reflecting a session where stock-specific swings mattered more than a broad sector-wide trend. The index settled at 26359.75, down 56.25 points or 0.21% from the previous close of 26416. Even though the headline move looks modest, the session beneath the surface was active. The index opened at 26470.75, touched an intraday high of 26549.10, and slipped to a low of 26192.85 before recovering part of the decline by the close.

For investors tracking pharma sector performance today, this was a mixed market. There were 9 advancing stocks, 10 declining stocks, and 1 unchanged stock in the index. That means the breadth was nearly balanced, but slightly tilted toward weakness. The advance-decline ratio stood at 0.90, while 45% of constituents ended in green and 50% ended in red. In plain language, Nifty Pharma was not under heavy selling pressure across the board, but a few notable declines in select constituents were enough to keep the sector index in the red.

This article gives a complete view of Nifty Pharma live performance for the day using verified index and constituent data. It covers the index snapshot, market breadth, complete stock-wise movement, top gainers, top losers, heavyweight stock action, practical interpretation of today’s trend, and what traders and investors may want to watch in the next session. Since the available dataset is price-and-breadth focused, the analysis below is built around actual trading movement in the index and its constituents.

Nifty Pharma Today: Sector Index Snapshot

The structure of the day suggests a range-bound but weak undertone. Nifty Pharma opened above the previous close, which indicated a stable start. It then tested higher levels near 26549.10 but could not hold there. The fall toward 26192.85 showed intraday pressure, but the rebound from the low also indicated that buyers were still active at lower levels. Because the index finally closed only 0.21% lower, the trend for the day can be described as sideways with a mild bearish bias rather than a sharp downtrend.

For beginners, the key takeaway is this: when an index opens firm, falls sharply intraday, and then recovers some losses, it usually points to mixed conviction. Bulls are willing to buy lower levels, but they are not strong enough yet to fully reverse the selling pressure. That was the broad character of Nifty Pharma today.

What Moved Nifty Pharma Today?

Based on the verified session data, Nifty Pharma’s movement today was driven mainly by divergent stock performance within the sector rather than a one-sided move across all pharma names. This is important because a sector index does not always fall because every stock is weak. Sometimes a few relatively stronger losers offset a larger number of modest gainers. Today’s breadth and constituent moves point to that kind of session.

The first visible drag came from sharp losses in individual names such as JB Chemicals & Pharmaceuticals Ltd., which fell 3.87%, and Torrent Pharmaceuticals Ltd., which declined 2.17%. Moves of this size stand out in a sector where many other constituents were up by less than 1%. That means even if several stocks advanced, the stronger negative moves likely had a larger effect on the overall tone of the index.

On the positive side, Granules India Ltd. rose 1.97%, Zydus Lifesciences Ltd. gained 1.11%, and Aurobindo Pharma Ltd. added 0.83%. These gains helped limit the downside, but they did not fully offset the sharper cuts in laggards.

Heavyweight behavior also mattered. Among the prominent pharma names tracked in the session, Sun Pharmaceutical Industries Ltd. slipped 0.08%, Cipla Ltd. fell 0.40%, and Dr. Reddy’s Laboratories Ltd. declined 0.45%, while Divi’s Laboratories Ltd. rose 0.32%. When heavyweight stocks are mixed like this, the index often remains trapped in a narrow range instead of making a decisive directional move. That is exactly what happened today.

So, if someone asks why Nifty Pharma is down today, the simplest factual answer is this: the sector saw a nearly even split between gainers and losers, but the declines in some individual stocks were sharper than the gains in most advancing names, keeping the index slightly lower at the close.

Market Breadth: How Broad Was Today’s Move?

Market breadth is one of the best ways to judge whether an index move is broad-based or narrow. In Nifty Pharma today, breadth was slightly negative. Ten stocks declined, nine advanced, and one stock closed unchanged. This tells us that weakness was not severe, but it was just enough to tilt the overall sector slightly lower.

The advance-decline ratio of 0.90 means that for every 10 declining stocks, there were roughly 9 advancing stocks. That is not a collapse. It is a sign of a competitive session between buyers and sellers. However, because the ratio stayed below 1, the bears had a small edge.

The difference between headline index movement and breadth is also useful here. A 0.21% decline in the index with almost balanced breadth usually points to selective pressure, not panic selling. For traders, that often means stock picking mattered more than simply taking a sector-wide bullish or bearish call. For investors, it suggests the pharma basket remains mixed, with pockets of strength and weakness visible at the same time.

Complete Nifty Pharma Constituent Performance

The top performer in the index today was Granules India Ltd., up 1.97%. The worst performer was JB Chemicals & Pharmaceuticals Ltd., down 3.87%. This wide spread between the best and worst performers is another sign that today was led by stock-specific moves rather than a uniform sector swing.

Top Gainers in Nifty Pharma Today

These gainers prevented Nifty Pharma from slipping further. The most notable point is that several gainers were positive by less than 1%, while the top losers fell by much larger percentages. So even though there were enough green stocks to keep breadth competitive, the upside lacked enough force to turn the whole index positive.

Among the gainers, Zydus Lifesciences Ltd. and Aurobindo Pharma Ltd. were especially important because both also appear among the session’s heavyweight names. Gains in such stocks often matter more for the overall sector tone than gains in smaller movers.

Top Losers in Nifty Pharma Today

The pressure from the losing side was more intense than the support from the gaining side. That is the central reason the index ended lower despite having nearly balanced breadth. In sector indices, magnitude often matters more than the simple count of gainers and losers. Here, the stronger percentage cuts in the red stocks were enough to pull the index below the previous close.

Heavyweight Stocks and Their Role in the Index

Heavyweight constituents often decide whether a sector index closes green or red. In Nifty Pharma today, heavyweight action was mixed. Divi’s Laboratories Ltd. gained 0.32%, Zydus Lifesciences Ltd. rose 1.11%, and Aurobindo Pharma Ltd. added 0.83%. On the other hand, Torrent Pharmaceuticals Ltd. declined 2.17%, Cipla Ltd. fell 0.40%, and Dr. Reddy’s Laboratories Ltd. slipped 0.45%.

Sun Pharmaceutical Industries Ltd., one of the most closely tracked names in the basket, was almost flat with a slight negative close of 0.08%. Mankind Pharma Ltd. was also close to flat at -0.04%, while Lupin Ltd. ended marginally positive at 0.01%. This kind of mixed behavior among major stocks usually caps both upside and downside and leads to an index that spends the day oscillating in a broad range.

Most Active Pharma Stocks in Focus

The list of most active pharma stocks today overlapped with the names that investors usually watch for sector direction: Sun Pharmaceutical Industries Ltd., Divi’s Laboratories Ltd., Torrent Pharmaceuticals Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Mankind Pharma Ltd., Zydus Lifesciences Ltd., Lupin Ltd., Abbott India Ltd., and Aurobindo Pharma Ltd..

When the active list is populated by sector leaders and established names, it often means traders are using liquid pharma counters to express their sector view. Since these stocks were split between gainers, losers, and near-flat closes, the activity supports the broader interpretation of a mixed and selective session rather than a clear broad-based bullish or bearish trend.

Short-Term Technical Reading Based on Price Structure

Using the available price structure alone, Nifty Pharma showed a sideways-to-mildly-bearish intraday setup. The index opened at 26470.75 and moved up to 26549.10, but the inability to hold the upper zone suggested resistance from sellers. It then dropped to 26192.85, which became the key lower end of the session’s range. A recovery from that low helped the index avoid a deeper negative close, but it still ended below the previous close.

For practical chart reading, today’s high and low form the immediate session range to watch. The upper band is near 26549.10, and the lower band is near 26192.85. A sustained move above the day’s high in a future session would indicate that buyers are regaining control over the short-term range. A break below the day’s low would indicate that sellers are extending the current weak undertone.

The close at 26359.75 places the index roughly in the lower half of the day’s total range, which is not ideal from a bullish perspective. At the same time, because the close was well above the intraday low, the market also showed dip-buying interest. That creates a balanced but cautious near-term picture.

In simple terms, the technical read from available data is this: Nifty Pharma has not broken down sharply, but it also has not shown enough strength to establish a clear upward continuation. Until either the day high or day low is decisively crossed, the sector may continue to trade with a stock-specific and range-bound bias.

Historical Session Perspective

This perspective shows the entire character of the day in one place. Nifty Pharma opened above the previous close, which pointed to early stability. It even extended gains intraday. However, the subsequent move to a low that was more than 223 points below the previous close showed that intraday sentiment weakened meaningfully before buyers emerged again. The final close only 56.25 points lower tells us the sector managed to recover a large part of its intraday damage.

That kind of pattern is usually important because it indicates both supply and demand were active. Sellers controlled the middle part of the session, but buyers prevented a weak finish near the day’s low. This creates a nuanced picture rather than a one-directional one.

What Investors Should Watch Next in Nifty Pharma

Based on today’s verified data, investors should closely track whether the next session confirms weakness or rewards the late-day recovery. The first thing to watch is breadth. If advancers start clearly outnumbering decliners, that would show broader support returning to the sector. If the ratio stays below 1 again, it would indicate that the current mild weakness remains in place.

The second thing to watch is the behavior of major pharma names. Mixed heavyweight action kept the index range-bound today. A stronger aligned move in stocks such as Sun Pharmaceutical Industries Ltd., Divi’s Laboratories Ltd., Cipla Ltd., Dr. Reddy’s Laboratories Ltd., and Torrent Pharmaceuticals Ltd. will likely shape the next directional move.

Third, traders may watch whether today’s strongest gainer, Granules India Ltd., can sustain momentum and whether today’s weakest stock, JB Chemicals & Pharmaceuticals Ltd., stabilizes. Leadership changes often reveal whether the sector is broadening out or becoming more defensive.

Finally, from a price-structure perspective, the session high of 26549.10 and the session low of 26192.85 now stand out as immediate reference points. Movement beyond either side of this range will likely provide the clearest short-term signal.

Key Takeaways

• Nifty Pharma closed at 26359.75, down 56.25 points or 0.21%.
• The index opened strong, touched 26549.10, fell to 26192.85, and recovered part of the decline by the close.
• Market breadth was slightly negative with 9 advancers, 10 decliners, and 1 unchanged stock.
• Granules India Ltd. was the top gainer at 1.97%.
• JB Chemicals & Pharmaceuticals Ltd. was the top loser at 3.87%.
• Heavyweight stocks were mixed, limiting the chance of a decisive sector-wide move.
• The day’s tone was sideways to mildly bearish rather than sharply weak.
• The immediate short-term range to watch is 26192.85 on the downside and 26549.10 on the upside.

Published on 21 August 2026 at 4:06 PM IST

Frequently Asked Questions

1. What is Nifty Pharma today?

Nifty Pharma today closed at 26359.75, down 56.25 points or 0.21% from the previous close of 26416.00.

2. Why is Nifty Pharma down today?

Nifty Pharma ended lower because declines in stocks like JB Chemicals & Pharmaceuticals Ltd. and Torrent Pharmaceuticals Ltd. were sharper than the gains in most advancing pharma stocks.

3. Was Nifty Pharma bullish or bearish today?

The session was sideways to mildly bearish. The index closed lower, but it also recovered from the intraday low, which prevented a weaker finish.

4. What was the opening value of Nifty Pharma today?

Nifty Pharma opened at 26470.75 on 21 August 2026.

5. What were the day high and day low of Nifty Pharma?

The index recorded a day high of 26549.10 and a day low of 26192.85.

6. How many stocks advanced in Nifty Pharma today?

9 stocks advanced in Nifty Pharma today.

7. How many stocks declined in Nifty Pharma today?

10 stocks declined, while 1 stock closed unchanged.

8. What was the advance-decline ratio in Nifty Pharma today?

The advance-decline ratio was 0.90, showing slightly weaker breadth for the sector.

9. Which stock gained the most in Nifty Pharma today?

Granules India Ltd. was the top gainer, rising 1.97%.

10. Which stock fell the most in Nifty Pharma today?

JB Chemicals & Pharmaceuticals Ltd. was the top loser, falling 3.87%.

11. Which major pharma stocks were mixed today?

Among prominent names, Divi’s Laboratories Ltd., Zydus Lifesciences Ltd., and Aurobindo Pharma Ltd. gained, while Torrent Pharmaceuticals Ltd., Cipla Ltd., and Dr. Reddy’s Laboratories Ltd. closed lower.

12. What should traders watch next in Nifty Pharma?

Traders can watch whether the index breaks above 26549.10 or below 26192.85, and whether breadth improves beyond today’s 9 advances versus 10 declines.